Join
Live feed
·
PRReleasevia Quantisnow
Vertex Pharmaceuticals Incorporated logo

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

ByQuantisnow·Wall Street's wire, on your screen.
VRTX· Vertex Pharmaceuticals Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRTX (Vertex Pharmaceuticals Incorporated) and more on Quantisnow.